King Luther Capital Management Corp reduced its stake in Bristol Myers Squibb by 3.5% in the third quarter, selling 18,602 shares and retaining 517,986 shares valued at approximately $23.36 million. Despite missing EPS estimates at $1.26 (vs. $1.65 consensus), Bristol Myers Squibb’s revenue of $12.50 billion surpassed forecasts, and the company raised its quarterly dividend to $0.63, reflecting a 4.2% yield. Institutional ownership remains high at 76.41%, and the stock currently has a “Hold” rating with an average price target of $60.19 among analysts.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
King Luther Capital Management Corp Sells 18,602 Shares of Bristol Myers Squibb Company $BMY
King Luther Capital Management Corp reduced its stake in Bristol Myers Squibb by 3.5% in the third quarter, selling 18,602 shares and retaining 517,986 shares valued at approximately $23.36 million. Despite missing EPS estimates at $1.26 (vs. $1.65 consensus), Bristol Myers Squibb’s revenue of $12.50 billion surpassed forecasts, and the company raised its quarterly dividend to $0.63, reflecting a 4.2% yield. Institutional ownership remains high at 76.41%, and the stock currently has a “Hold” rating with an average price target of $60.19 among analysts.